PharVision Advisers LLC Decreases Holdings in Bath & Body Works, Inc. $BBWI

PharVision Advisers LLC trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 11.1% in the first quarter, Holdings Channel reports. The firm owned 8,344 shares of the company’s stock after selling 1,043 shares during the period. PharVision Advisers LLC’s holdings in Bath & Body Works were worth $253,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. T. Rowe Price Investment Management Inc. boosted its position in Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after purchasing an additional 781,681 shares during the period. Victory Capital Management Inc. boosted its position in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock worth $206,119,000 after purchasing an additional 6,752,274 shares during the period. Alliancebernstein L.P. boosted its position in Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock worth $164,397,000 after purchasing an additional 243,611 shares during the period. AQR Capital Management LLC boosted its position in Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after purchasing an additional 2,907,506 shares during the period. Finally, GMT Capital Corp lifted its holdings in Bath & Body Works by 7.3% in the 1st quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock worth $113,327,000 after buying an additional 255,600 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on BBWI. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Citigroup cut their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Barclays boosted their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a report on Friday, August 29th. UBS Group cut their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Finally, Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an “overweight” rating in a report on Thursday, May 15th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $41.62.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $29.49 on Friday. The firm has a market cap of $6.08 billion, a PE ratio of 8.75, a price-to-earnings-growth ratio of 1.01 and a beta of 1.49. The firm’s 50-day simple moving average is $30.73 and its 200-day simple moving average is $30.51. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company’s revenue for the quarter was down .8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio is 23.74%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.